Historical record - last NADAC effective date: 10/18/2023
Product Information
ACETAZOLAMIDE ER 500 MG CAP is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.3218 per EA under NDC 50742023301. Its NADAC has been published 319 times since Oct 4, 2017.
FDA first approved this application on Sep 30, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742023301
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
10/18/2023
Active Ingredients
ACETAZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA203434FDA Approved
9/30/2016
TE Code
AB
On Market Since
7/31/2017
Pharmacological Classes
Price Statistics
The NADAC for ACETAZOLAMIDE ER 500 MG CAP has been published 319 times since Oct 4, 2017, and over the history we have for it it has declined 80.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3218 per EA |
|---|---|
| All-time high | $1.6931 (Nov 15, 2017) |
| All-time low | $0.3201 (Aug 23, 2023) |
| Median price | $0.4901 |
| Average price | $0.6541 |
| Largest weekly change | +39.0% (Nov 18, 2020) |
| Weeks tracked | 319 |
| Tracking since | Oct 4, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-9.1%
5Y
-22.6%
All
-80.0%
Last surveyed Nov 8, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 12% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ACETAZOLAMIDE ER 500 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ACETAZOLAMIDE ER 500 MG CAP, manufactured by Ingenus Pharmaceuticals LLC, is $0.3218 per EA (NDC 50742023301), effective Nov 8, 2023.
How has the price of ACETAZOLAMIDE ER 500 MG CAP changed over time?
Over the history we have for it, the NADAC for ACETAZOLAMIDE ER 500 MG CAP has declined 80.0%. It has been tracked across 319 weekly CMS publications since Oct 4, 2017.
What are the highest and lowest recorded NADAC prices for ACETAZOLAMIDE ER 500 MG CAP?
Since Oct 4, 2017, the NADAC for ACETAZOLAMIDE ER 500 MG CAP has ranged from a low of $0.3201 (Aug 23, 2023) to a high of $1.6931 (Nov 15, 2017), with a median of $0.4901 per EA.
Are there cheaper alternatives to ACETAZOLAMIDE ER 500 MG CAP?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETAZOLAMIDE ER 500 MG CAP, is $0.2838 per EA — about 12% below ACETAZOLAMIDE ER 500 MG CAP.
Who manufactures ACETAZOLAMIDE ER 500 MG CAP?
ACETAZOLAMIDE ER 500 MG CAP (NDC 50742023301) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.